The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
10% of the US population has a rare genetic condition they may or may not know it but that's just true in terms of these monogenic factors that we've been talking about so that's 10% of the population if you now think about the you know percentage of the population that's obese or that has obesity or type 2 diabetes or some of these other common conditions that someday might be treated by these one andone types of things
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.